EUVIMEDEUVIMED entdecken
Leserbrief

Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG ‐asparaginase

Laure Goursaud, Celine Berthon, Bruno Quesnel iD

British Journal of Haematology · 2023-02 · 200 (4)

DOI: 10.1111/bjh.18595 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 05.12.2022. Verfasst von Laure Goursaud und 2 weiteren Autor:innen. Beteiligte Einrichtung: CHU Lille, Service des Maladies du Sang, Lille, France. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Institut pour la Recherche sur le Cancer de Lille.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic AgentsHumansAsparaginasePolyethylene GlycolsCell- and Tissue-Based TherapyAntineoplastic Combined Chemotherapy ProtocolsSulfonamidesBridged Bicyclo Compounds, Heterocyclic

Stichwörter der Autor:innen

PEG-asparaginasecell therapyleukaemiarefractoryvenetoclax

Substanzen

AsparaginasePolyethylene GlycolsAntineoplastic AgentspegaspargasevenetoclaxSulfonamidesBridged Bicyclo Compounds, Heterocyclic

Autor:innen und Institutionen

  • CHU Lille, Service des Maladies du Sang, Lille, France.
  • CNRS, Inserm, UMR9020 - UMR-S 1277 - Canther - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.
  • Univ. Lille, Lille, France.

ORCID-Profile: Bruno Quesnel

Förderung

  • Institut pour la Recherche sur le Cancer de Lille

Zitieren

APA

Goursaud, L., Berthon, C., & Quesnel, B. (2023). Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG ‐asparaginase. British Journal of Haematology, 200(4). https://doi.org/10.1111/bjh.18595

Vancouver

Goursaud L, Berthon C, Quesnel B. Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG ‐asparaginase. British Journal of Haematology. 2023;200(4). doi:10.1111/bjh.18595

BibTeX
@article{Goursaud2023,
  author = {Goursaud, Laure and Berthon, Celine and Quesnel, Bruno},
  title = {Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG ‐asparaginase},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {200},
  number = {4},
  doi = {10.1111/bjh.18595}
}
Kostenlos starten →